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ABSTRACT
Dopamine responsive dystonia (DRD) is a dystonic syndrome of childhood, usually affecting gait. It presents with
walking difﬁculties, spasticity or dystonia with a characteristic diurnal variation and MRI brain scan is normal in it. It
may however develop into Parkinsonism later, which shows dramatic therapeutic response to levodopa.
A 25 year old lady presented with difﬁculty in walking along with weakness and stiffness of both legs at Neurology
OPD of Chandka Medical College Hospital,Larkana. After reaching at proper diagnosis of DRD, treatment was
started. As a result of which, she showed dramatic improvement and was able to return back to her routine life.

INTRODUCTION

nerves were intact. On motor examination, she had
normal bulk, tone, power& reﬂexes in both upper
limbs.Whereas in lower limbs, bulk was normal and
tone was increased (legs were spastic on touching and
remained in that position for few seconds & then
resolved itself). Power was 0/5 in lower limbs.
However, reﬂexes were normal with ﬂexor planter
response. Sensory system & Cerebellar system were
intact and gait was not assessed.Whereas, rest of the
systemic examination was unremarkable.On slit lamp
examination, noKayser-Fleischer ring was found and
fundus examination was normal too.
Her complete blood count, ESR, electrolytes, serum
calcium level, vitamin D level, liver function test, urine
detail report were normal, the serum cerulopalsmin&
24hour urinary copper level were in normal range. Her
radiographic studies chest x-ray, lumbo-sacral spine,
CT scan brain were unremarkable, MRI lumbo-sacral
spine was also normal.
Sinemet12.5mg/50mg (L-dopa 50 mg + Carbidopa
12.5 mg) was startedat a dosage of half tablet twice
worsened further&shebecame completely immobile.
She, however, had full control of her sphincters.There
was no other such similar family history. Birth history of
the patient was unremarkable and developmental
milestones were normal too with proper immunization
history.
On Examination, patient was conscious. She was
oriented to time, place & person with stable vitals and

Dopamine-responsive dystonia (DRD), also known as
dopa-responsive dystonia or as Segawa disease, is an
inherited autosomal dominant dystonia typically
presenting in ﬁrst decade of life (although it may
present in second to early third decades, or even later).
It is characterized by diurnal ﬂuctuations, exquisite
responsiveness to levodopa, and mild Parkinsonian
features, as well as by striatal dopamine deﬁciency.
The signs of Parkinsonism are relatively subtle in DRD.
These signs may include slowness of movement,
stiffness and resistance to movement (rigidity),
balance difﬁculties and postural instability. These
Parkinsonian features often respond well to regular
doses of levodopa (a synthetic form of the brain
chemical, dopamine).
CASE REPORT
A 25 year old lady presented in the outpatient
department of a tertiary care hospital atLarkana,
Pakistan with chief complaints of difﬁculty in walking,
weakness and stiffness of both legs for three years.
According to the patient's attendant she was in her
usual state of health three years back when she ﬁrst
observed difﬁculty in walking which then increased
slowly & gradually. After some time owing to unsteady
gait, she started using acane. But her condition subvitals. Her higher mental functions and cranial
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Postural tremor, which is not observed in childhood,
appears after the third decade. Resting tremor and
rigidity are absent, and inter limb coordination is
preserved (even in advanced cases).
Bradykinesia may develop. This is not due to failure of
initiation and poverty of movement as in Parkinsonism;
rather, it is due to failure of reciprocal innervation
resulting from the dystonia.
Muscle tone is increased and deep tendon reﬂexes are
exaggerated (with ankle clonus). The plantar reﬂex is
21
ﬂexor, although striatal toe is common.[ ]

DISCUSSION
Dopamine responsive dystonia (DRD) encompasses a
group of clinically and genetically heterogeneous
disorders that typically manifest as limb-onset,
diurnally ﬂuctuating dystonia and exhibit a robust and
sustained response to levodopa treatment. Autosomal
dominant GTP cyclohydrolase 1 deﬁciency, also
known as Segawa disease, is the most common and
best-characterized condition that manifests as DRD.
Dopamine responsive dystonia (DRD) is estimated to
affect 1 per million people worldwide. Mutations in the
GCH1 gene are the most common cause of doparesponsive dystonia. Less often, mutations in the TH
or SPR gene cause this condition.Dopamine is
produced from tyrosine by the action of tyrosine
hydroxylase (TH , which uses tetrahydrobiopterin
(BH4) as a cofactor. BH4 is also a cofactor for
tryptophan and serotonin synthesis, as well as for the
enzyme nitrous oxide synthetase. The ﬁrst rate-limiting
step for BH4 synthesis is GCH. The gene for GCH has
been cloned to 14q 22.1-22.2 and is the gene
responsible for autosomal-dominant DRD/HPD.
Mutations in the GCH1 gene are found across the
entire gene; 99 of the 104 mutant alleles are present in
a heterozygous state and cause DRD in a dominant
fashion with reduced penetrance. [2] More than 50% of
patients with autosomal-dominant inherited DRD have
mutations in the GCH1 gene.[3,4,5,6,7]
Point mutation in the gene for SR has been detected in
patients who have autosomal-recessive DRD. SRrelated DRD has been shown to be similar to, yet
somewhat more severe than, TH-deﬁcient DRD.[8]
Despite advances in the understanding of DRD,
genetic testing is not deﬁnitive. Thirty percent to 40% of
patients with DRD do not show the common mutations.
Girls are affected more than boys with ratio of 2 or 3:1.
The most common presenting symptom of dopamineresponsive dystonia (DRD) is a gait disturbance.
These patients may be misdiagnosed as having
cerebral palsy. Typically, the dystonia starts in 1 lower
limb (with evening exacerbation), resulting in a tiptoe
(equinus) walking pattern. Early in the disease course,
patients are symptom free in the morning. Diurnal
aggravation of symptoms depends more on the
number of waking hours than on physical activity. The
disease progresses markedly in the ﬁrst 15 years, with
postural dystonia progressing to all 4 limbs (even in the
morning) by the end of the second decade.
Progression slows in the third decade and plateaus
21
thereafter. [ ] The dystonia is variable in severity,
depending on the duration of disease prior to
treatment. Gait disturbance is characterized by leg
stiffness and a tendency to walk in an equinus posture.
The great toe is dorsiﬂexed. Gait tends to worsen later
in the day. With increasing age and without treatment,
dystonia spreads to involve the trunk and all 4
extremities.
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DIAGNOSIS
The diagnosis of DRD is not made by one deﬁnitive
test, but by a series of clinical observations and
speciﬁc biochemical assessments. Deﬁning the
exact cause may not be possible.
A therapeutic trial with levodopa remains the most
practical initial approach to diagnosis. Even an
adverse reaction may help illuminate details about the
cause and warrant additional tests, and not all DRD
p a t i e n t s r e s p o n d t o l e v o d o p a i m m e d i a t e l y.
Furthermore, not all individuals who are carriers will
exhibit symptoms. A detailed family history is an
important element of diagnosis.
Obtaining a cerebrospinal ﬂuid sample (via lumbar
puncture) is an important component of diagnosing
DRD. This may be the most straightforward way to
obtain a preliminary diagnosis and distinguish among
possible metabolic conditions. There remains a
chance that the cerebrospinal test will not provide a
deﬁnitive diagnosis. It is crucial that the patient stop
taking levodopa at least a week before the
cerebrospinal ﬂuid collection.
Speciﬁc metabolic defects may be detected by an oral
phenylalanine loading test, but the test is not 100%
sensitive and the scope is limited. False negatives may
occur with this test, detecting only about 80% of cases
of DRD. Similarly, there are tests for very speciﬁc
metabolic conditions that do not address the entire
scope of possible deﬁciencies.
DRD must be distinguished from other disorders with
similar symptoms including cerebral palsy, early-onset
generalized dystonia, spastic paraplegia, and
disorders which cause childhood-onset parkinsonism.
Patients and family members should understand that
diagnosing DRD can be challenging, but that there are
steps toward differentiating among the various types.
TREATMENT
Symptoms of DRD can usually be treated effectively
with a drug called levodopa, and most often a
combination of levodopa and carbidopa. In many
cases, full physical functionality including walking,
running, speaking, and writing is restored or
preserved.
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